Two Sigma Advisers’s ARS Pharmaceuticals SPRY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $719K | Buy |
41,200
+300
| +0.7% | +$5.24K | ﹤0.01% | 1590 |
|
|
2025
Q1 | $515K | Sell |
40,900
-100
| -0.2% | -$1.26K | ﹤0.01% | 1765 |
|
|
2024
Q4 | $433K | Sell |
41,000
-400
| -1% | -$4.22K | ﹤0.01% | 1836 |
|
|
2024
Q3 | $600K | Buy |
41,400
+17,100
| +70% | +$248K | ﹤0.01% | 1625 |
|
|
2024
Q2 | $207K | Buy |
+24,300
| New | +$207K | ﹤0.01% | 2203 |
|
|
2023
Q3 | – | Sell |
-226,800
| Closed | -$1.52M | – | 2563 |
|
|
2023
Q2 | $1.52M | Buy |
226,800
+6,000
| +3% | +$40.2K | ﹤0.01% | 1342 |
|
|
2023
Q1 | $1.44M | Sell |
220,800
-23,300
| -10% | -$152K | ﹤0.01% | 1450 |
|
|
2022
Q4 | $2.08M | Sell |
244,100
-25,700
| -10% | -$219K | 0.01% | 1222 |
|
|
2022
Q3 | $1.43M | Sell |
269,800
-156,900
| -37% | -$829K | ﹤0.01% | 1350 |
|
|
2022
Q2 | $1.81M | Buy |
426,700
+55,900
| +15% | +$237K | 0.01% | 1270 |
|
|
2022
Q1 | $1.3M | Buy |
370,800
+144,100
| +64% | +$506K | ﹤0.01% | 1488 |
|
|
2021
Q4 | $1.51M | Buy |
226,700
+189,100
| +503% | +$1.26M | ﹤0.01% | 1325 |
|
|
2021
Q3 | $375K | Buy |
+37,600
| New | +$375K | ﹤0.01% | 2030 |
|